PADELETTI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.578
EU - Europa 7.896
AS - Asia 4.493
SA - Sud America 694
AF - Africa 130
Continente sconosciuto - Info sul continente non disponibili 103
OC - Oceania 94
Totale 25.988
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.397
RU - Federazione Russa 2.467
PL - Polonia 1.557
IT - Italia 1.426
SG - Singapore 1.325
CN - Cina 972
HK - Hong Kong 744
IE - Irlanda 596
SE - Svezia 583
BR - Brasile 541
VN - Vietnam 520
KR - Corea 382
DE - Germania 351
FI - Finlandia 262
UA - Ucraina 214
FR - Francia 204
IN - India 166
GB - Regno Unito 133
CA - Canada 107
AU - Australia 94
TR - Turchia 64
JO - Giordania 61
AR - Argentina 56
BD - Bangladesh 45
JP - Giappone 40
ID - Indonesia 35
CI - Costa d'Avorio 31
MX - Messico 27
ZA - Sudafrica 26
EC - Ecuador 24
IQ - Iraq 22
CO - Colombia 19
NL - Olanda 19
PK - Pakistan 19
VE - Venezuela 19
ES - Italia 17
MA - Marocco 16
UZ - Uzbekistan 15
CL - Cile 14
NG - Nigeria 14
CR - Costa Rica 11
SC - Seychelles 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
KE - Kenya 9
SA - Arabia Saudita 9
AZ - Azerbaigian 8
BE - Belgio 8
KG - Kirghizistan 8
MY - Malesia 8
PH - Filippine 8
RO - Romania 8
BO - Bolivia 7
TH - Thailandia 7
GT - Guatemala 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
EG - Egitto 5
JM - Giamaica 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
DZ - Algeria 4
HN - Honduras 4
IR - Iran 4
KZ - Kazakistan 4
NP - Nepal 4
AL - Albania 3
AT - Austria 3
BH - Bahrain 3
GE - Georgia 3
GR - Grecia 3
LT - Lituania 3
MU - Mauritius 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
CG - Congo 2
HU - Ungheria 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PY - Paraguay 2
SN - Senegal 2
SV - El Salvador 2
TJ - Tagikistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BM - Bermuda 1
BS - Bahamas 1
BW - Botswana 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
Totale 25.872
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.089
Warsaw 1.556
Ashburn 1.329
Fairfield 1.201
Singapore 947
Hong Kong 595
Dublin 594
Chandler 557
Seattle 547
Woodbridge 543
Cambridge 525
San Jose 469
Houston 457
Wilmington 414
Jacksonville 408
Seoul 382
Milan 308
Beijing 258
Ann Arbor 205
Council Bluffs 196
Princeton 173
The Dalles 171
Los Angeles 167
Ho Chi Minh City 153
Rome 150
Buffalo 146
Lawrence 146
Altamura 135
Lauterbourg 134
Munich 120
Hanoi 117
Mumbai 115
Boston 113
Boardman 106
Hefei 105
Medford 86
Melbourne 83
San Diego 76
Moscow 67
Turku 66
Dallas 64
Florence 64
Phoenix 62
New York 61
Helsinki 54
Kent 52
São Paulo 50
Naples 41
Izmir 38
Norwalk 36
Bologna 35
Tokyo 35
Falls Church 34
Shanghai 34
Paris 33
Figino 32
Turin 31
Abidjan 30
Dong Ket 28
Columbus 27
Orem 27
Clifton 24
Guangzhou 23
Toronto 22
Chicago 21
London 21
Da Nang 20
Haiphong 20
Jakarta 20
Palermo 20
Redondo Beach 20
Tianjin 20
Brasília 18
Montreal 18
Frankfurt am Main 17
Brooklyn 15
Hillsboro 15
Verona 15
Catania 14
Atlanta 13
Frankfurt Am Main 13
Andover 12
Belo Horizonte 12
Miano 12
Abuja 11
Brescia 11
Genoa 11
Shenzhen 11
Auburn Hills 10
Redwood City 10
Salvador 10
San José 10
Tashkent 10
Yubileyny 10
Ankara 9
Bari 9
Bern 9
Biên Hòa 9
Chennai 9
Johannesburg 9
Totale 17.440
Salva come PNG Salva come JPEG
Nome #
Multiple shocks affect thoracic electrical impedance during external cardioversion of atrial fibrillation. 371
Short- and long-term cardiac events in patients with chest pain with or without known existing coronary disease presenting normal electrocardiogram. 345
Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. 332
ATRIAL FIBRILLATION AND CANCER: EVIDENCE FOR AN EPIDEMIOLOGICAL LINK 328
Atrial Fibrillation After Cardiac Surgery: Incidence, Risk Factors, and Economic Burden 324
Clinical management of atrial fibrillation: early interventions, observation, and structured follow-up reduce hospitalizations. 322
Aggressive approach and outcome in patients presenting atrial fibrillation and hypertension 307
Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure 296
Obstructive sleep apnea after myocardial infarction. 276
Impact of one or two visits strategy on hypertension burden estimation in HYDY, a population-based cross-sectional study: implications for healthcare resource allocation decision making. 272
Comparison of the usefulness of cardiac resynchronization therapy in three age-groups (<65, 65-74 and ≥75 Years) (from the InSync/InSync ICD Italian Registry). 249
Hemodynamic sensor in cardiac implantable electric devices: the endocardial accelaration technology 240
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 237
Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. 228
Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. 219
AGT and ACE genes influence classic mitral valve prolapse predisposition in Marfan patients 217
Management of patients with acute atrial fibrillation in the ED 217
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 209
Effects of smoking in patients treated with cardiac resynchronization therapy 207
Dual-site left ventricular cardiac resynchronization therapy. 204
Effects of cryoablation and radiofrequency ablation on endothelial and blood clotting activation 204
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 203
Cardiac memory in humans: vectocardiographic quantification in cardiac resynchronization therapy. 197
A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. 197
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. 196
A contribution for validation of ECG criteria for interatrial conduction delay. 195
Cardiac resynchronization therapy: gender related differences in left ventricular reverse remodeling. 194
Concordant Versus Discordant Left Bundle Branch Block in Heart Failure Patients: Novel Clinical Value of an Old Electrocardiographic Diagnosis 193
Thoracic electric impedance and its changes after multiple shocks for external cardioversion of atrial fibrillation. A role for acute inflammatory response? 193
Determinants of all-cause mortality in different age groups in patients with severe systolic left ventricular dysfunction receiving an implantable cardioverter defibrillator (from the Italian ClinicalService Multicenter Observational Project) 193
Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation 192
Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure 192
Cardiac resynchronization therapy improves functional status and cognition 191
Multicenter experience with implantable defibrillators subject to recall. 190
Arterial stiffness and left ventricular performance in elderly patients with persistent atrial fibrillation 189
QRS duration in left bundle branch block does not affect left ventricular twisting in chronic systolic heart failure 188
Simplified Selvester Score: a practical electrocardiographic instrument to predict response to CRT 188
Cardiac Resynchronization Therapy Acutely Improves Ventricular-Arterial Coupling by Reducing the Arterial Load: Assessment by Pressure-Volume Loops. 187
Larger interventricular conduction time enhances mechanical response to resynchronization therapy 187
Autoantibodies against β1-Adrenergic Receptors: Response to Cardiac Resynchronization Therapy and Renal Function 187
Effects of ischemia and reperfusion on QT dispersion during coronary angioplasty 186
Acute effects of His bundle pacing versus left ventricular and right ventricular pacing on left ventricular function. 185
Left ventricular mass and progenitor cells in chronic heart failure patients 184
Abnormal troponin level as short-term predictor of poor outcome in acute atrial fibrillation. 182
Prognostic impact of atrial fibrillation occurrence in patients with non-ST-elevation acute coronary syndromes: is dysrhythmia duration a parameter to focus on? 179
213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 179
Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. 179
The evolution of cardiac electrophysiology in the XIX century: historical highlights. 177
Age-related effects on mortality of the implantable cardioverter defibrillator. An analysis of the Italian clinical service project database 177
Cardiac effects of clomipramine treatment 176
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 176
Atrial standstill disease progression documented after 13 years follow-up 175
Electrophysiologic procedures and activation of the hemostatic system 174
Bioavailability of digoxin-hydroquinone complex 173
Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: The MINERVA randomized multicentre international trial 171
Echo/Doppler-derived time intervals are able to predict left ventricular reverse remodeling after cardiac resynchronization therapy 170
Temporal Variation in Optimal Atrioventricular and Interventricular Delay During Cardiac Resynchronization Therapy 169
Which factors predict the behavior of ventricular extrasystoles in athletes over time? 168
Rotational mechanics of the left ventricle in AL amyloidosis 168
Long-term Prognostic Value of Dysglycemia and Ischemic Vascular Disease Beyond Abnormal Troponin Levels in Patients Presenting Acute Atrial Fibrillation. 165
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA) 165
Enhanced cardiac norepinephrine release in patients with idiopathic ventricular tachycardia related to the occurrence of arrhythmias 163
ATRIAL FIBRILLATION AND CARDIAC RESYNCHRONIZATION THERAPY: THE MASCOT STUDY. 162
Activation of the coagulation system during electrophysiologic invasive study with and without ablation 162
La morte cardiaca improvvisa in Italia. Dimensioni, percezioni, politiche 162
Activation of hemostatic system during electrophysiological procedures 161
Implantable cardioverter defibrillator in sport participation. 161
Circadian Pattern of the QT Dispersion Using 3 Orthogonal Leads of an Holter ECG in Patients with Heart Failure. 161
Sex-related differences in chronic heart failure 158
Rational bases for the therapy of supraventricular tachycardias and their management 156
Resynchronization of mitral valve annular segments reduces functional mitral regurgitation in cardiac resynchronization therapy 155
Diagnostic accuracy of extended-length electrocardiogram in differentiating between athlete's heart and hypertrophic cardiomyopathy. 155
Atrial fibrillation in athletes 154
Rhythmic and haemodynamic determinants of long-term survival after radiofrequency ablation of atrial fibrillation in mitral valve surgery 154
Digoxin and congestive heart failure. 153
Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy 153
Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation 152
Evolution and prognostic significance of diastolic filling pattern in cardiac resynchronization therapy. 151
Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response 150
Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial. 150
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy 150
Is a dual-sensor pacemaker appropriate in patients with sino-atrial disease? Results from the DUSISLOG study. 149
Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy. 149
Cardiac amyloidosis: the heart of the matter. 148
Altered values of heart rate variability in patients with relapse of atrial fibrillation during the first week after electrical cardioversion: peliminary data 147
External cardioversion of atrial fibrillation causes an early improvement of cardiac performance: A longitudinal strain analysis study 147
Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure 146
Koch and the "ultimum moriens" theory - the last part to die of the heart 146
Atrioventricular interval optimazation in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements 141
Non-traumatic splenic rupture on dual antiplatelet therapy with aspirin and ticagrelor after stenting for acute coronary syndrome 140
Pacemaker selection: time for a rethinking of complex pacing systems? 139
Women and ICD: The Influence of Age and Clinical Characteristics on Survival; the Experience of the Italian ClinicalService Multicenter Observational Project 138
Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. 137
Arterial hypertension and atrial fibrillation: standard and advanced echocardiography from diagnosis to prognostication 136
Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass. 135
Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction. 134
Cardiac amyloidosis: the heart of the matter. 133
Surgical treatment of single gingival recessions: clinical guidelines 133
Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients. 132
Prospective randomized study to assess the efficacy of site and rate of atrial pacing on long-term progression of atrial fibrillation in sick sinus syndrome septal pacing for atrial fibrillation suppression evaluation (SAFE) study 132
Totale 18.719
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022905 0 0 71 43 48 56 28 70 72 56 168 293
2022/20232.528 274 431 95 178 181 465 376 145 242 16 84 41
2023/2024836 57 105 176 53 59 109 32 159 3 17 45 21
2024/20256.488 227 712 437 1.058 1.888 711 86 330 397 154 267 221
2025/20267.011 730 977 458 560 695 300 837 390 430 422 138 1.074
2026/2027894 238 243 413 0 0 0 0 0 0 0 0 0
Totale 25.988